EIB (n = 22) | TB-AOI (n = 20) | |
---|---|---|
Female gender – no. (%) | 17 (77) | 11 (55) |
Age – years | ||
Median (IQR) | 43 (8.3) | 38 (17.8) |
Country of origin – no. (%) | ||
TB-HBC* | 18 (82) | 14 (70) |
History of latent TB†− no. (%) | 4 (18) | 4 (20) |
Duration of Symptoms – months (years) | n = 19 | n = 15 |
Median | 24 (2) | 9 (0.8) |
IQR | 30 (2.5) | 13 (1.1) |
Diagnostics‡ | ||
TST | n = 16 | n = 16 |
Range - induration (mm) | 10–30 | 12–40 |
Median (IQR) | 18 (7) | 17.5 (7.8) |
IGRA | n = 13 (7 had TST) | n = 15 (11 had TST) |
Positive result – no. (%) | 12 (92) | 13 (87) |
Chest X-ray | n = 22 | n = 20 |
TB changes§ – no. (%) | 4 (18) | 1 (5) |
Tissue Biopsy Pathology# | n = 17 | |
Granulomatous inflammation | 15 (88) | No samples obtained for |
Necrobiosis | 9 (53) | pathology |
Panniculitis | 10 (59) | |
Vasculitis | 8 (47) |